Cargando…

Cost-effective, green HPLC determination of losartan, valsartan and their nitrosodiethylamine impurity: application to pharmaceutical dosage forms

Angiotensin-converting enzyme inhibitors are one of the most widely used anti-hypertensive drugs which are used to reduce hypertension. In 2018, the United States Food and Drug Administration together with the European Medicine Agency declared the presence of carcinogenic nitrosamine impurities such...

Descripción completa

Detalles Bibliográficos
Autores principales:	Abd El-Hay, Soad S., Elhenawee, Magda, Maged, Khaled, Ibrahim, Adel Ehab
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	The Royal Society 2022
Materias:	Chemistry
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9156911/ https://www.ncbi.nlm.nih.gov/pubmed/35706671 http://dx.doi.org/10.1098/rsos.220250

Ejemplares similares

Development and validation of eco-friendly micellar-HPLC and HPTLC-densitometry methods for the simultaneous determination of paritaprevir, ritonavir and ombitasvir in pharmaceutical dosage forms
por: Ibrahim, Adel Ehab, et al.
Publicado: (2019)

Development and validation of an eco-friendly HPLC–UV method for determination of atorvastatin and vitamin D(3) in pure form and pharmaceutical formulation
por: Maged, Khaled, et al.
Publicado: (2023)

Development and Validation of four Nitrosamine Impurities Determination Method in Medicines of Valsartan, Losartan, and Irbesartan with HPLC-MS/MS (APCI)
por: Khorolskiy, Mikhail, et al.
Publicado: (2021)

Core–shell particles and monolithic columns; tools for simultaneous LC analysis of avanafil, sildenafil, apomorphine, trazodone, yohimbine, tramadol and dapoxetine in pharmaceutical dosage forms, counterfeit products and human plasma
por: Ibrahim, Adel Ehab, et al.
Publicado: (2020)

Development and Validation of a Precise, Single HPLC Method for the Determination of Tolperisone Impurities in API and Pharmaceutical Dosage Forms
por: Raju, Thummala Veera Raghava, et al.
Publicado: (2013)

RP-HPLC Method for the Determination of Losartan Potassium and Ramipril in Combined Dosage Form
por: Rao, K. Srinivasa, et al.
Publicado: (2010)

Determination of d-Cycloserine Impurities in Pharmaceutical Dosage Forms: Comparison of the International Pharmacopoeia HPLC–UV Method and the DOSY NMR Method
por: Makuc, Damjan, et al.
Publicado: (2020)

Management of validation of HPLC method for determination of acetylsalicylic acid impurities in a new pharmaceutical product
por: Kowalska, Małgorzata, et al.
Publicado: (2022)

QbD based development of HPLC method for simultaneous quantification of Telmisartan and Hydrochlorothiazide impurities in tablets dosage form
por: Palakurthi, Ashok K., et al.
Publicado: (2020)

A Stability-Indicating HPLC Method for the Determination of Fingolimod in Pharmaceutical Dosage Forms
por: Souri, Effat, et al.
Publicado: (2015)

A Stability Indicating HPLC Method for the Determination of Fluvoxamine in Pharmaceutical Dosage Forms
por: Souri, Effat, et al.
Publicado: (2015)

Stability-Indicating HPLC Determination of Trandolapril in Bulk Drug and Pharmaceutical Dosage Forms
por: Al-Hawash, Leena A., et al.
Publicado: (2015)

Development and Validation of Ecofriendly HPLC-MS Method for Quantitative Assay of Amoxicillin, Dicloxacillin, and Their Official Impurity in Pure and Dosage Forms
por: Almalki, Atiah H., et al.
Publicado: (2021)

Adjusted green HPLC determination of nirmatrelvir and ritonavir in the new FDA approved co-packaged pharmaceutical dosage using supported computational calculations
por: Imam, Mohamed S., et al.
Publicado: (2023)

Application of HPLC for the Simultaneous Determination of Aceclofenac, Paracetamol and Tramadol Hydrochloride in Pharmaceutical Dosage Form
por: Chandra, Preeti, et al.
Publicado: (2012)

Stability-Indicating RP-HPLC Method for Determination of Tamsulosin HCL in Pharmaceutical Dosage Form
por: Kumar, G S, et al.
Publicado: (2012)

Stability-Indicating RP-HPLC Method for the Determination of Ambrisentan and Tadalafil in Pharmaceutical Dosage Form
por: Patel, Jayvadan K., et al.
Publicado: (2014)

Development and Validation of a Stability-Indicating RP-HPLC Method for the Estimation of Drotaverine Impurities in API and Pharmaceutical Formulation
por: Thummala, Veera Raghava Raju, et al.
Publicado: (2014)

Green Chemometric Determination of Cefotaxime Sodium in the Presence of Its Degradation Impurities Using Different Multivariate Data Processing Tools; GAPI and AGREE Greenness Evaluation
por: Sharaf, Yasmine Ahmed, et al.
Publicado: (2023)

Simultaneous Determination of Valsartan and Hydrochlorothiazide in Tablets by RP-HPLC
por: Tian, D. F., et al.
Publicado: (2008)

Novel Validated Stability-Indicating UPLC Method for the Estimation of Naproxen and its Impurities in Bulk Drugs and Pharmaceutical Dosage Form
por: Venkatarao, Papanaboina, et al.
Publicado: (2012)

Recent trends in the impurity profile of pharmaceuticals
por: Pilaniya, Kavita, et al.
Publicado: (2010)

Application of Box-Behnken experimental design and response surface methodology for selecting the optimum RP-HPLC conditions for the simultaneous determination of methocarbamol, indomethacin and betamethasone in their pharmaceutical dosage form
por: Elkady, Ehab F., et al.
Publicado: (2022)

Effect of Route of Administration on the Carcinogenic Action of Diethylnitrosamine (N-Nitrosodiethylamine)
por: Herrold, Katherine McD.
Publicado: (1964)

Simultaneous Estimation of Nebivolol Hydrochloride and Valsartan using RP HPLC
por: Kokil, S. U., et al.
Publicado: (2009)

New Stability Indicating RP-HPLC Method for the Estimation of Cefpirome Sulphate in Bulk and Pharmaceutical Dosage Forms
por: Rao, Kareti Srinivasa, et al.
Publicado: (2011)

Application of Narrow-Bore HPLC Columns in Rapid Determination of Sildenafil Citrate in Its Pharmaceutical Dosage Forms
por: Ghodsi, Razieh, et al.
Publicado: (2012)

Valsartan addition to amlodipine is more effective than losartan addition in hypertensive patients inadequately controlled by amlodipine
por: Fogari, Roberto, et al.
Publicado: (2010)

Risk of myocardial infarction, heart failure, and cerebrovascular disease with the use of valsartan, losartan, irbesartan, and telmisartan in patients
por: Yoo, Yung-Geun, et al.
Publicado: (2023)

A Novel, Validated Stability-Indicating UPLC Method for the Estimation of Lansoprazole and its Impurities in Bulk Drug and Pharmaceutical Dosage Forms
por: Rao, Papanaboina Venkata, et al.
Publicado: (2013)

HPLC in the pharmaceutical industry /
Publicado: (1991)

HPLC Method for Simultaneous Determination of Impurities and Degradation Products in Zonisamide
por: Vijayakumar, E. K. S., et al.
Publicado: (2009)

HPLC-Based Analysis of Impurities in Sapropterin Branded and Generic Tablets
por: Scudellaro, Emanuela, et al.
Publicado: (2020)

Organic Salts of Pharmaceutical Impurity p-Aminophenol
por: Khandavilli, U. B. Rao, et al.
Publicado: (2020)

Development and validation of stability indicating the RP-HPLC method for the estimation of related compounds of guaifenesin in pharmaceutical dosage forms
por: Reddy, Sunil Pingili, et al.
Publicado: (2011)

RP-HPLC Method Development and Validation for Determination of Eptifibatide Acetate in Bulk Drug Substance and Pharmaceutical Dosage Forms
por: Bavand Savadkouhi, Maryam, et al.
Publicado: (2017)

Protective Effects of Garlic Oil on Hepatocarcinoma Induced by N-Nitrosodiethylamine in Rats
por: Zhang, Cui-Li, et al.
Publicado: (2012)

Analysis of N-nitrosodiethylamine by ion chromatography coupled with UV photolysis pretreatment
por: Li, Xueli, et al.
Publicado: (2016)

HPTLC Method for the Simultaneous Estimation of Valsartan and Hydrochlorothiazide in Tablet Dosage Form
por: Shah, N. J., et al.
Publicado: (2009)

Analytical Performance and Greenness Evaluation of Five Multi-Level Design Models Utilized for Impurity Profiling of Favipiravir, a Promising COVID-19 Antiviral Drug
por: Ibrahim, Adel Ehab, et al.
Publicado: (2022)

Cannot write session to /tmp/vufind_sessions/sess_4rotic89ddufeeutf985t1giem